World Health Organization. Breast and cervical cancer in countries between and a systematic analysis. Surveillance of screening-detected cancers colon and rectum, breast, and cervix - United States, Prognostic value of histopathology and trends in cervical cancer: a SEER population study. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Cancer Res. Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women. Surveillance Epidemiology and End Results. Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet. Screening pelvic examination in adult women: a clinical practice guideline from the American College of Physicians. Bankhead C. ACP: no need for routine pelvic exams. MedPage Today. June 30, Screening pelvic examinations in asymptomatic, average-risk adult women: an evidence report for a clinical practice guideline from the American College of Physicians.
Cervical Cancer: Screening. September ; Accessed: January 25, Barclay L. Cervical screening guidelines updated. March 21, Accessed: April 5, J Low Genit Tract Dis. Causes and relevance of unsatisfactory and satisfactory but limited smears of liquid-based compared with conventional cervical cytology. Arch Pathol Lab Med. Staging of uterine cervical carcinoma: whole-body diffusion-weighted magnetic resonance imaging.
Abdom Imaging. The Bethesda System: terminology for reporting results of cervical cytology. Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study. American Joint Committee on Cancer. Cervix uteri. New York: Springer; Topical 5-fluorouracil for treatment of cervical intraepithelial neoplasia 2: a randomized controlled trial.
Am J Obstet Gynecol. Brown T. Jaunary 9, Accessed: January 19, Fertility outcome after radical vaginal trachelectomy: a prospective study of patients. Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy. Radical vaginal trachelectomy vs. A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer.
Robotic radical hysterectomy versus total laparoscopic radical hysterectomy with pelvic lymphadenectomy for treatment of early cervical cancer. Survival outcomes for women undergoing type III robotic radical hysterectomy for cervical cancer: a 3-year experience. Therapeutic role of lymphadenectomy for cervical cancer. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study.
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas.
Number 35, May American College of Obstetricians and Gynecologists. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the year experience at UCLA.
Lung cancer complications: What you should know
Chemotherapy for advanced, recurrent, and metastatic cervical cancer. J Natl Compr Canc Netw. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. US Food and Drug Administration. FDA approves Avastin to treat patients with aggressive and late-stage cervical cancer [news release]. Accessed: August 15, Lowes R.
Message sent successfully
August 14, Accessed: August 20, Improved survival with bevacizumab in advanced cervical cancer. Mulcahy N. Bevacizumab changes practice in advanced cervical cancer.
February 19, Accessed: February 25, Chustecka Z. Bevacizumab prolongs survival in advanced cervical cancer. June 2, Accessed: June 24, Incorporation of bevacizumab in the treatment of recurrent and metastatic cervical cancer: A phase III randomized trial of the Gynecologic Oncology Group. Asco University.
NPR Choice page
Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. Male human papillomavirus prevalence and association with condom use in Brazil, Mexico, and the United States.
- Neurologic Complications of Cancer?
- Sherlocks Hornpipe / The Strand.
- Cancer - Symptoms and causes - Mayo Clinic!
- La griffe du destin (Nocturne) (French Edition).
Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med.
http://gohu-takarabune.com/policy/programa/kiquv-rastrear-celular.php Centers for Disease Control and Prevention. ACIP Recommendations. Accessed: April 17, Brooks M. One HPV shot may be enough to protect against cervical cancer. November 4, Accessed: November 13, Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica vaccine trial.